Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators

Surgery

Volumn 136, Issue 2, 2004, Pages 346-354

  Weldon, Christopher B ^a   Elliott, Steven ^a   Zhu, Yun ^a   Clayton, John L ^a   Curiel, Tyler J ^a   Jaffe, Bernard M ^a   Burow, Matthew E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COACTIVATOR PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; PROTEIN; PROTEIN P160; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; COLONY FORMING CELL; CONTROLLED STUDY; ENZYMATIC ASSAY; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; STATISTICAL SIGNIFICANCE;

ACETYLTRANSFERASES; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; ESTROGENS; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TAMOXIFEN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3843088561     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.05.010     Document Type: Article

References (26)

1. Kiess W., Gallaher B. Hormonal control of programmed cell death/apoptosis. European Journal of Endocrinology. 138:1998;482-491
2. Simstein R., Burow M.E., Parker A., Weldon C.B., Beckman B.S. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 228:2003;995-1003
3. Burow M.E., Weldon C.B., Tang Y., McLachlan J.A., Beckman B.S. Oestrogen-mediated suppression of TNF-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol. 78:2001;409-418
4. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol Rev. 81:2001;1535-1565
5. Clarke R., Leonessa F., Welch J.N., Skaar T.C. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev. 53:2001;25-71
6. Ali S., Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nature Reviews Cancer. 2:2002;101-112
7. Xu J., Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol. 17:2003;1681-1692
8. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev. 20:1999;321-344
9. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids. 65:2000;227-251
10. Tai H., Kubota N., Kato H. Involvement of nuclear receptor coactivator SRC-1 in estrogen dependent cell growth of MCF-7 cells. Biochem Biopys Res Comm. 267:2000;311-313
11. List H.J., Lauritsen K.J., Reiter R., Powers C., Wellstein A., Riegel A.T. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem. 276:2001;23763-23768
12. Cavarretta I.T., Mukopadhyay R., Lonard D.M., Cowsert L.M., Bennett C.F., O'Malley B.W., et al. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation. Mol Endocrinol. 16:2002;253-270
13. Kurebayashi J., Otsuki T., Kunisue H., Tanaka K., Yamamoto S., Sonoo H. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin Cancer Res. 6:2000;512-518
14. Thenot S., Charpin M., Bonnet S., Cavailles V. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol. 156:1999;85-93
15. Murphy L.C., Simon S.L., Parkes A., Leygue E., Dotzlaw H., Snell L., et al. Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res. 60:2000;6266-6271
16. Berns E.M., van Staveren I.L., Klijn J.G., Foekens J.A. Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer. Breast Cancer Res Treat. 48:1998;87-92
17. Chan C.M., Lykkesfeldt A.E., Parker M.G., Dowsett M. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. Clin Cancer Res. 5:1999;3460-3467
18. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMs. Science. 295:2002;2465-2468
19. Weldon C.B., Burow M.E., Rolfe K.W., Clayton J.L., Jaffe B.M., Beckman B.S. NF-κB-mediated chemoresistance in breast cancer cells. Surgery. 130:2001;143-150
20. Burow M.E., Boue S.B., Collins-Burow B.M., Melnik L.I., Duong B.N., Li S.F., et al. Phytochemical glyceollins, isolated from soy, mediate anti-hormonal effects through estrogen receptor alpha and beta. J Clin Endocrinol and Metabolism. 86:2001;1750-1758
21. Li C.J., Li Y.-Z., Pinto A.V., Pardee A.B. Potent inhibition of tumor survival in vivo by β-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci U S A. 96:1999;13369-13374
22. Burow M.E., Weldon C.B., Tang Y., Navar G.L., Krajewski S., Reed J.C., et al. Differences in susceptibility to tumor necrosis factor-a-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research. 58:1998;4940-4946
23. Wu R.C., Qin J., Hashimoto Y., Wong J., Xu J., Tsai S.Y., et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol Cell Biol. 22:2002;3549-3561
24. Geistlinger T.R., Guy R.K. Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2. J Am Chem Soc. 125:2003;6852-6853
25. Northrop J.P., Nguyen D., Piplani S., Olivan S.E., Kwan S.T., Go N.F., et al. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries. Mol Endocrinol. 14:2000;605-622
26. Norris J.D., Paige L.A., Christensen D.J., Chang C.Y., Huacani M.R., Fan D., et al. Peptide antagonists of the human estrogen receptor. Science. 285:1999;744-746